Skyscape Web Viewer : The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs : Main Index

View All
Barriers to deprescribing Barriers and Facilitators to Deprescribing Tapering Psychiatric Drugs in Practice
Bead counting/weighing Practical Options for Prescribing Gradually Tapering Doses Practical Options in Prescribing Gradually Tapering Doses of Antidepressants
Beneficial effects antidepressants gabapentinoids Why Deprescribe? benzodiazepines and z-drugs Tapering Psychiatric Drugs in Practice
Bipolar disorder Distinguishing Antidepressant Withdrawal Symptoms from New Onset of a Physical or Mental Health Condition Tapering Benzodiazepines and Z-Drugs in Practice When and Why to Stop Gabapentinoids Distinguishing Benzodiazepine Withdrawal Symptoms from Return of an Underlying Condition When and Why to Stop Benzodiazepines and Z-Drugs
Boxed warning (black box warn- ing) How to Deprescribe Benzodiazepines and Z-Drugs Safely When and Why to Stop Benzodiazepines and Z-Drugs Protracted Benzodiazepine Withdrawal Syndrome Withdrawal Symptoms from Benzodiazepines and Z-Drugs
British National Formulary (BNF) Other Considerations in Tapering Benzodiazepines and Z-Drugs Practical Options in Prescribing Gradually Tapering Doses of Antidepressants Other Considerations in Tapering Gabapentinoids
Buspirone Buspirone Other Considerations in Tapering Benzodiazepines and Z-Drugs
Benzodiazepines
Bleeding risks
Buproprion